Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Includes masking products including but not limited to synthetic urine, human urine, a substance used or designed to be added to human urine or a substance used or designed to be added to a chemical test, within the definition of drug-related paraphernalia.
Requires the office of addiction services and supports to assure that persons who suffer from a substance use disorder have the right to seek and receive addiction services, care, treatment and rehabilitation services based on the individual's gender identity, gender expression and/or sexual orientation.
Relates to the distribution of educational materials regarding the misuse of and addiction to prescription drugs in counties with the most prevalent abuse of prescription opioids.
Provides that when informational cards or sheets about opioid antagonists are distributed, such information shall include information about fentanyl strips and their uses.
Directs the commissioner of health to establish guidelines for onsite opioid overdose response capacity in community centers; defines "community center".
Authorizes certain facilities to provide treatment for the mental health and health care needs of individuals admitted for a substance use disorder; provides that such services shall be reimbursable by Medicaid and private insurance.